This is one example of CURE Epilepsy’s influence on the field, where supporting a promising scientist early in their career has exponential impact
View this email in your browser ([link removed])
** CURE Epilepsy Discovery
------------------------------------------------------------
[link removed]
** Researchers Funded to Investigate Cardiac Biomarkers in Epilepsy Thanks to CURE Epilepsy ([link removed])
------------------------------------------------------------
Dr. Auerbach’s scientific work is just one example of CURE Epilepsy’s influence on the field, where supporting a promising scientist early in their career has exponential impact when they go on to gain additional government funding, train new epilepsy researchers, and advance their research which will ultimately impact the millions of people living with epilepsy.
Epileptic seizures (ES) are caused by disturbances in electrical activity in the brain. However, in 20-40% of individuals whose seizures are not controlled by antiseizure medications, seizure activity does not correlate with changes in an electroencephalogram (EEG).[1] These seizures are classified as psychogenic non-epileptic seizures (PNES), also known as functional or dissociative seizures (FDS).[2] Many people with FDS have experienced abuse, trauma, or neglect. FDS can co-occur with depressive disorders, personality disorders, and post-traumatic stress disorders. FDS are often debilitating and are associated with a decreased quality of life, substantial emotional burden, and financial and psychosocial loss.[3,4] There is value to the epilepsy field in understanding and studying FDS for several reasons: first, ES and FDS can co-exist,[5] and second, both ES and FDS can impact the cardiac system, leading to changes in heart rate, arrhythmias, and other abnormalities seen on an
electrocardiogram (ECG).[6,7] Disturbances in the autonomic nervous system have been seen in individuals with ES and FDS, and this is especially true in drug-resistant epilepsy and cases of Sudden Unexpected Death in Epilepsy (SUDEP ([link removed]) ).[8,9]
It is important to be able to differentiate between ES and FDS because the characteristics and treatment options for each differ. Similar to ES, there is a high risk of sudden death in individuals with FDS. Alarmingly, those with FDS have 2.5 times the rate of sudden death compared to the general population.[10] People with suspected FDS may undergo testing in an epilepsy monitoring unit using video EEG, but tests done there can lead to inconclusive results. Not being able to properly diagnose FDS can have many detrimental impacts such as delays in getting proper treatment, and inappropriate or even inadvertently dangerous medical treatment.[11,12] Hence, there is an urgent need to develop ways to diagnose FDS and differentiate ES from FDS.
Read More ([link removed])
Today's CURE Epilepsy Discovery has the ability to help the 65 million people worldwide who are impacted by epilepsy every day.
And each one of those individuals has a story.
[link removed]
Read Nora’s Story ([link removed])
[link removed]
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research.
CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed] [link removed]
Copyright (C) 2023 CURE Epilepsy. All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])
This email was sent to
[email protected] (mailto:
[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
